| Ms Brianna Craite, MS, CF-SLP | |
|
2869 Duke St, Alexandria, VA 22314-4512 | |
| (703) 299-0051 | |
| (703) 299-0052 |
| Full Name | Ms Brianna Craite |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 2869 Duke St, Alexandria, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336581008 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 2202007010 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Brianna Craite, MS, CF-SLP 2869 Duke St, Alexandria, VA 22314-4512 Ph: (703) 299-0051 | Ms Brianna Craite, MS, CF-SLP 2869 Duke St, Alexandria, VA 22314-4512 Ph: (703) 299-0051 |
News Archive
David H. Fater, CEO of Vicor Technologies, Inc., today announced the initial results of a study designed to analyze data from the Merte Subita en Insufficiencia Cardiaca Trial using its PD2i- algorithm and software. Vicor Technologies is a biotechnology company focused on the development of innovative, non-invasive medical devices using its patented, proprietary PD2i- nonlinear algorithm and software.
Scientists report in Nature Neuroscience they have identified an underlying cause of dangerous immune suppression in people with high level spinal cord injuries and they propose a possible treatment.
An 18-year follow-up study of postmenopausal women in the Women's Health Initiative trials has shown that the use of hormone therapy was not associated with any increased risk of all-cause, cardiovascular or cancer death.
Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company developing Tovaxin®, a personalized T-cell immunotherapy for multiple sclerosis (MS), today announced that it has achieved its first technology transfer milestone in connection with the company's recently announced exclusive stem cell agreement with Novartis, one of the world's largest healthcare companies. The milestone was completed on schedule and triggers a payment of $500,000 to Opexa.
A webinar on JCAHO Emergency Department Core Measures: Achieving Successful Quality Outcomes is being presented by Compirion Healthcare Solutions to aid Hospital Emergency Departments in instituting treatment standards as defined by the Joint Commission, for AMI, CHA and CAP patients. Compliance with JCAHO Core Measures produces better outcomes for the patient while assuring maximum MSI reimbursement to the hospital.
› Verified 7 days ago
Tammy L Pilgrim, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1510 Collingwood Rd, Alexandria, VA 22308 Phone: 703-765-6107 | |
Nicole Ann Ladia, M.S.ED., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6116 Bangor Dr, Alexandria, VA 22303 Phone: 571-239-3688 | |
Ms. Shunnae A Baker, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1340 Braddock Pl, Alexandria, VA 22314 Phone: 510-432-7301 | |
Despina Timbinaris, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5236 Ballycastle Cir, Alexandria, VA 22315 Phone: 571-344-0792 | |
Fabiola Santos, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1340 Braddock Pl, Alexandria, VA 22314 Phone: 703-619-8000 | |
Beth Blake Harrison, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5708 Callcott Way Unit A, Alexandria, VA 22312 Phone: 703-678-5692 | |
Danielle Hyde, M.A. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8111 Tis Well Dr, Alexandria, VA 22306 Phone: 814-218-4029 |